BPL Medical Technologies has supported the launch of India’s first AI-enabled mobile cancer screening unit, marking a significant step in expanding access to preventive diagnostics. The initiative was unveiled in Hyderabad on World Cancer Day, reinforcing efforts to take advanced imaging technologies beyond hospitals and into underserved communities.
The mobile screening bus was launched at Basavatarakam Indo-American Cancer Hospital & Research Institute and formally flagged off by Shri Nandamuri Balakrishna Garu, Chairman of the institute. The event was attended by members of the hospital’s trust board, clinicians, and senior healthcare leaders.
Equipped with AI-enabled mobile digital radiography and digital mammography systems from BPL Medical Technologies, the unit is designed to deliver reliable screening services in non-traditional settings. Its mobile format allows outreach into rural and low-access regions, helping bridge gaps in diagnostic infrastructure and supporting earlier detection of cancer.
Commenting on the initiative, Shravan Subramanyam, Managing Director of BPL Medical Technologies, said that early detection remains one of the most effective ways to improve cancer outcomes. He noted that the mobile unit reflects the company’s focus on deploying scalable technologies that bring quality diagnostics closer to communities and strengthen preventive care efforts.
Building on innovations showcased at IRIA 2026, BPL Medical Technologies continues to position itself as a technology partner for healthcare providers seeking AI-driven diagnostic solutions. The mobile cancer screening bus aligns with the company’s broader objective of combining clinical relevance with technological advancement to address India’s evolving healthcare needs.
BPL designs and manufactures a wide portfolio of Made-in-India medical devices, including patient monitors, ventilators, ultrasound and X-ray systems, digital health solutions, and consumer health products. With 14 regional offices and a workforce of more than 500 professionals, BPL serves healthcare providers across both urban and rural India.
The company has reported a 16.9% CAGR between 2014 and 2024, and is targeting 32% growth in the next fiscal year. BPL has received multiple recognitions, including Best Healthcare Brand (The Economic Times) and Most Leading Brand in Medical Equipment (Medgate Today). The company is backed by Claypond Capital, the family office of Ranjan Pai.
